An Open-Label Study on the Effect of Flax Seed Powder (Linum usitatissimum) Supplementation in the Management of Diabetes Mellitus
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is characterized by hyperglycemia and associated with aberrations in the metabolism of carbohydrate, protein, and lipid that result in development of secondary complications. Extensive studies have indicated that nutritional therapy plays a pivotal role in the controlling or postponing of development of these secondary complications. Several functional foods have been shown to possess hypoglycemic and hypolipidemic properties. Flax seed (FS) is a functional food that is rich in omega 3 fatty acids and antioxidants and is low in carbohydrates. In exploratory studies, FS was incorporated in recipes, which resulted in a reduction in the glycemic index of the food items. These observations prompted us to investigate the efficacy of FS supplementation in type 2 diabetics (n = 29). Subjects were assigned to the experimental (n = 18) or the control group (n = 11) on the basis of their desire to participate in the study. The experimental group's diet was supplemented daily with 10 g of FS powder for a period of 1 month. The control group received no supplementation or placebo. During the study, diet and drug intake of the subjects remained unaltered. The efficacy of supplementation with FS was evaluated through a battery of clinico-biochemical parameters. Supplementation with FS reduced fasting blood glucose by 19.7% and glycated hemoglobin by 15.6%. A favorable reduction in total cholesterol (14.3%), triglycerides (17.5%), low-density lipoprotein cholesterol (21.8%), and apolipoprotein B and an increase in high-density lipoprotein cholesterol (11.9%) were also noticed. These observations suggest the therapeutic potential of FS in the management of diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 2×
“…that insulin resistance, hyperinsulinemia, impaired insulin secretion, reduced insulin-mediated glucose uptake/utilization (DeFronzo, 1997; Groop et al., 1989; Polonsky, Sturis, & Bell, 1996), and chronic hyperglycemia are the key factors responsible for causing multiple secondary…”
BackgroundMeta-analysis of the effects of flaxseed interventions on blood lipids
Pan, A., Yu, D., Demark-Wahnefried, W., Franco, O. H., & Lin, X. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27469 · Cited by 264 · cited 2×
“Some studies conducted during the past few years and our recent observations have shown that FS possesses hypoglycemic and hypolipemic (Pan et al., 2009) properties and cause foods to have a lower glycemic index (Mani & Gianchandani, 2005).”
ResultRole of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Parikh, P., Mani, U., & Iyer, U. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152744463 · Cited by 193
Self-citationMani, U. V., Desai, S., & Iyer, U. (2000) · Journal of Nutraceuticals, Functional & Medical Foods · doi:10.1300/j133v02n03_03 · Cited by 94
Self-citation
Cited by
Flax and flaxseed oil: an ancient medicine & modern functional food
Goyal, A., Sharma, V., Upadhyay, N., Gill, S., & Sihag, M. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-013-1247-9 · Cited by 742
Trichopoulou, A., Martínez-González, M. A., Tong, T. Y., Forouhi, N. G., Khandelwal, S., Prabhakaran, D., Mozaffarian, D., & de Lorgeril, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-112 · Cited by 656
Dietary Flaxseed as a Strategy for Improving Human Health
Parikh, M., Maddaford, T. G., Austria, J. A., Aliani, M., Netticadan, T., & Pierce, G. N. (2019) · Nutrients · doi:10.3390/nu11051171 · Cited by 265
Phytotherapy in the management of diabetes: A review
Governa, P., Baini, G., Borgonetti, V., Cettolin, G., Giachetti, D., Magnano, A., Miraldi, E., & Biagi, M. (2018) · Molecules · doi:10.3390/molecules23010105 · Cited by 182
“usitatissimum seed powder (10 g/day for 1 month), containing not quantifiedω-3 fatty acids and lignans, reduced fasting blood glucose, glycated hemoglobin, triglycerides, total and LDL cholesterol and apolipoprotein B, and increase HDL cholesterol levels in type 2 diabetes patients [153].”
BackgroundYari, Z., Rahimlou, M., Eslamparast, T., Ebrahimi-Daryani, N., Poustchi, H., & Hekmatdoost, A. (2016) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2016.1161011 · Cited by 118
Metadata
- Authors
- Mani, U. V., Mani, I., Biswas, M., & Kumar, S. N.
- Venue
- Journal of Dietary Supplements
- Publisher
- Informa UK Limited
- Published
- 2011-07-15
- Volume
- 8
- Issue
- 3
- Pages
- 257-265
- ISSN
- 1939-0211 (ISSN-L)
- 1939-022X
- OpenAlex
- W1978691660
- Cited by
- 85
- References
- 4
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Open-Label Study on the Effect of Flax Seed Powder (Linum usitatissimum) Supplementation in the Management of Diabetes Mellitus. https://app.cochat.ai/papers/10.3109/19390211.2011.593615
- The paper
- Mani, U. V., Mani, I., Biswas, M., & Kumar, S. N. (2011). An Open-Label Study on the Effect of Flax Seed Powder (Linum usitatissimum) Supplementation in the Management of Diabetes Mellitus. Journal of Dietary Supplements. https://doi.org/10.3109/19390211.2011.593615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.